Who owns Crescent Biopharma Inc?
- Ticker: CBIO
- CUSIP Number: g2545c104
Tip: Access positions for across all investors
Analyze quarterly positions in Crescent Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Crescent Biopharma stock
Who bought or sold Crescent Biopharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| FMR | 4.1M | $49M | 192% | Dec 2025 |
|
| BVF | 2.7M | $33M | 98% | Dec 2025 |
|
| Fairmount Funds Management | 2.7M | $33M | 98% | Dec 2025 |
|
| VR Adviser | 2.1M | $25M | 54% | Dec 2025 |
|
| Fcpm Iii Services B.v. | 1.7M | $20M | 100% | Dec 2025 |
|
| Vestal Point Capital | 1.5M | $18M | 100% | Dec 2025 |
|
| Opaleye Management | 1.2M | $14M | 100% | Dec 2025 |
|
| Tang Capital Management | 872k | $10M | 28% | Dec 2025 |
|
| ADAR1 Capital Management | 606k | $7.2M | 100% | Dec 2025 |
|
| Logos Global Management | 600k | $7.1M | 0% | Dec 2025 |
|
| Vanguard Group | 558k | $6.6M | -15% | Dec 2025 |
|
| Deep Track Capital | 454k | $5.4M | 0% | Dec 2025 |
|
| Boxer Capital Management | 454k | $5.4M | 0% | Dec 2025 |
|
| Perceptive Advisors | 454k | $5.4M | 0% | Dec 2025 |
|
| Rtw Investments | 373k | $4.4M | 100% | Dec 2025 |
|
| Driehaus Capital Management | 303k | $3.6M | 0% | Dec 2025 |
|
| Point72 Asset Management | 300k | $3.6M | 100% | Dec 2025 |
|
| Alyeska Investment Group | 264k | $3.1M | 100% | Dec 2025 |
|
| Heights Capital Management | 264k | $3.1M | 100% | Dec 2025 |
|
| Wellington Management Company | 143k | $1.6M | 710% | Dec 2025 |
|
| Two Sigma Investments | 125k | $1.5M | 342% | Dec 2025 |
|
| Balyasny Asset Management | 112k | $1.3M | 100% | Dec 2025 |
|
| BlackRock | 109k | $1.3M | 0% | Dec 2025 |
|
| Geode Capital Management | 91k | $1.1M | 32% | Dec 2025 |
|
| Stonepine Capital Management | 88k | $1.0M | 100% | Dec 2025 |
|
| Blackstone Group | 76k | $897k | 0% | Dec 2025 |
|
| Burkehill Global Management | 74k | $844k | 100% | Dec 2025 |
|
| Woodline Partners | 74k | $878k | 100% | Dec 2025 |
|
| Leucadia National Corporation | 64k | $762k | -37% | Dec 2025 |
|
| Millennium Management | 62k | $734k | 100% | Dec 2025 |
|
| Susquehanna International | 57k | $677k | 100% | Dec 2025 |
|
| Renaissance Technologies | 47k | $554k | 74% | Dec 2025 |
|
| Two Sigma Advisers | 33k | $386k | 100% | Dec 2025 |
|
| State Street Corporation | 26k | $311k | 41% | Dec 2025 |
|
| Goldman Sachs Group | 25k | $299k | -32% | Dec 2025 |
|
| Moore Capital Management | 25k | $297k | 100% | Dec 2025 |
|
| Manufacturers Life Insurance Company | 25k | $289k | 0% | Dec 2025 |
|
| Jane Street | 23k | $272k | 100% | Dec 2025 |
|
| Marshall Wace | 22k | $259k | -50% | Dec 2025 |
|
| Northern Trust | 17k | $204k | 2% | Dec 2025 |
|
| Hrt Financial | 13k | $155k | 100% | Dec 2025 |
|
| OMERS Administration Corporation | 12k | $138k | 100% | Dec 2025 |
|
| UBS Group | 7.1k | $85k | -44% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 3.6k | $43k | 89525% | Dec 2025 |
|
| Tower Research Capital | 409.00 | $4.9k | 104% | Dec 2025 |
|
| SBI Securities | 68.00 | $805.997200 | 0% | Dec 2025 |
|
| Efficient Wealth Management | 40.00 | $0 | 100% | Dec 2025 |
|
| Fortitude Family Office | 40.00 | $735.000000 | 100% | Mar 2026 |
|
| Advisor Group Holdings | 26.00 | $308.001200 | 0% | Dec 2025 |
|
| Group One Trading | 4.00 | $47.000000 | -95% | Dec 2025 |
|
Who sold out of Crescent Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Commodore Capital | Sep 2025 | 451k | $5.4M |
| Frazier Life Sciences Management | Sep 2025 | 273k | $3.2M |
| Adage Capital Partners GP | Sep 2025 | 200k | $2.4M |
| Soleus Capital Management | Sep 2025 | 200k | $2.4M |
| Citadel Advisors | Sep 2025 | 26k | $304k |
| Affinity Asset Advisors | Sep 2025 | 18k | $214k |